Orion Porfolio Solutions, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1360533
OMAHA, NE
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$787,944
+$112,647 QoQ
Shares Held
6,428
+0.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#185
of 341 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $65,856,861 across 60 Biotechnology names. PTGX ranks #28 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,853 | $5,887,740 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
23,454 | $5,651,710 | |
| 3 | RPRX |
Royalty Pharma plc
|
99,319 | $5,568,816 | |
| 4 | INSM |
INSMED Inc
|
35,467 | $3,781,491 | |
| 5 | ARGX |
Argenx SE
|
2,471 | $2,292,519 | |
| 6 | INVA |
Innoviva, Inc.
|
92,707 | $2,105,375 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
24,870 | $1,971,942 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,491 | $1,874,492 |
All Filings in PTGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $787,944 | 6,428 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $675,297 | 6,407 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $383,946 | 4,396 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $460,227 | 6,928 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $364,782 | 6,600 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $325,511 | 6,731 | Shares | Sole | 2025-08-01 | |
| 2024-09-30 | $275,130 | 6,114 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | $255,994 | 7,388 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||